ArticleNeurosurgical review2025
Early and late outcomes following surgical treatment of chronic subdural hematoma: a six-year retrospective cohort study.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic subdural hematoma (CSDH) is a common neurosurgical disease, particularly in elderly patients, with variable clinical behavior and potential recurrence. Knowing both early and late postoperative results is paramount in optimizing patient management and reducing morbidity. We retrospectively analyzed 580 adult patients with CSDH who underwent burr-hole craniostomy from 2017 to 2023. Early (≤3 months) and late (>3 months) clinical and radiological outcomes were assessed. Hematoma volume and midline shift (MLS) were quantified using Infinitt PACS, a validated semi-automated segmentation platform, with an inter-rater intraclass correlation coefficient (ICC) exceeding 0.90, by neuroradiologists blinded to clinical data. Multivariate logistic regression identified independent predictors of recurrence. The cohort's mean age was 63.2 ± 19.2 years, with males comprising 79.8%. Postoperative imaging demonstrated substantial reductions in hematoma thickness and MLS (>88%). Recurrence rate was 7.2%. Residual postoperative hematoma thickness (Odds Ratio 1.185; p < 0.001) and MLS (OR 1.180; p = 0.015) were significant independent predictors of recurrence. Parietal burr-hole placement was associated with superior radiological outcomes compared to frontal approaches (p = 0.004). Late follow-up data underscored sustained recovery correlated with younger age and higher admission GCS scores. Integrating volumetric imaging with validated semi-automated assessment and standardized functional grading provides a robust framework for risk stratification in CSDH. Early and late postoperative evaluations reveal key predictors of recurrence and functional outcome. These findings support tailored surgical approaches complemented by vigilant postoperative follow-up to optimize patient care and reduce recurrence rates.
Indexed as
Identifiers
41413741What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.